Adjuvant Combo May Change Practice in High-Risk Liver Cancer
(MedPage Today) -- ORLANDO -- For the first time, adjuvant therapy has improved recurrence-free survival (RFS) after surgery or ablation for hepatocellular carcinoma (HCC), the most common type of liver cancer, according to the randomized IMbrave050...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Urology & Nephrology